Skip to main content
1/1 journal selected

Vaccine

Japanese Society for Vaccinology (Japan)

Elsevier (Netherlands)

VACCINE is the pre-eminent journal for those interested in vaccines and vaccination. It serves as an interface between academics, those in research and development, and workers in the field. Relevant topics range from basic

VACCINE is the pre-eminent journal for those interested in vaccines and vaccination. It serves as an interface between academics, those in research and development, and workers in the field. Relevant topics range from basic research through to applications, safety and legislation. Key aspects include: human, veterinary, disease prevention, physiological manipulation, molecular biology, synthetic peptides, recombinant antigens, vectors, new immunogens, adjuvants, animal models, immunity, immunology of protection, fertility, academic research, developmental applications, field trials, clinical trials, laboratory productions, industrial production, social implications, epidemiology, efficacy, safety, legislation, regulation, cost/benefit. These aspects may be applied to diseases caused by: viruses, bacteria, mycoplasma, protozoa, fungi, helminths, arthropods,prions

Animal health: multidiscip.
Human health
Open access
  • Author-paid optional open access
Self-archiving
Publication languages
  • English
Journal reputation
Abbreviated title (ISO)
Vaccine
ISSN L
0264-410X
Frequency
12 issues/year (Monthly)
Additional information

Embargo : 12 mois après publication de l'article, la version post-print peut être déposée sur une archive ouverte (ex : Agritrop).

Article types
Research articles
Reviews
Short articles
Special issues
Letters
Publishing costs
No
Cost of optional open access
3350 $ (updated 01/01/2022)
Research data access policy
Deposit recommended
Last updated : 03/01/2023

Ask a question, make a suggestion,
suggest a correction :

ou-publier@cirad.fr